Perform world-class research—advance our understanding of cancer genomics
Illumina next-generation sequencing (NGS) and microarray technologies represent the gold standard in quality worldwide—and account for ~90% of the world’s sequencing data.* Innovative, intuitive, and completely integrated, our sample-to-data solutions empower your lab to keep ahead of the curve in the rapidly evolving genomics revolution. So you’ll be better able to perform the world-class cancer genomics research you strive for—with the goal of uncovering new insights into the biology of cancer that can lead to meaningful advances in personalized medicine.
Our comprehensive genomics product offerings support multiple cancer research applications, including studies of DNA, RNA, epigenetics, and more. Our range of sequencers can be scaled to meet your needs—from powerful, yet personal, benchtop models to versatile, high-throughput systems. With intuitive data analysis and management capabilities and unsurpassed customer support, we can deliver the answers you seek—quickly, accurately, and cost-effectively.
Cancer Genomics Research Topics
Explore genomics-based approaches to investigating cancer using NGS and microarrays.
- Cancer Sequencing Methods
- Cancer Immunotherapy Research
- Cancer Epigenetics
- Chromosomal Abnormalities
- Products and Services
Cancer Sequencing Methods
NGS methods enable cancer researchers to perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
Cancer Immunotherapy Research
Immuno-oncology is an emerging field that has taken great strides in the fight against cancer, bolstered by a refined understanding of how tumors evade the natural immune response. Research into the mechanisms tumors use to inhibit the immune response have led to promising therapeutic targets.
Cancer Epigenetics
Changes in gene activation or gene silencing can impact the rate of cancer progression. Studying the epigenetic changes that influence gene expression can provide insight into important tumorigenic pathways.
Chromosomal Abnormalities
Genomic instability and chromosomal abnormalities are common features of cancer. Understanding these structural aberrations can inform studies of cancer etiology.
Products and Services
Illumina offers various NGS and microarray products and services to support cancer genomics research.
Immune Profiling Identifies CD73 as a Combinatorial Target in Glioblastoma
Swetha Anandhan highlights the use of single cell RNA-sequencing to identify a unique population of macrophages in glioblastoma multiforme that persists after treatment with immune checkpoint inhibitors.
View Webinar
Recent Cancer Genomics Articles
NEJM Study Shows WGS Improves Molecular Profiling
Side-by-side comparison shows WGS produced more accurate results in less time and at a similar cost
Read Article
Using Analytics to Improve Cancer Diagnosis and Therapy Selection
Developing and automating best-practice workflows that make analyzing, processing, and disseminating genomic data accessible to researchers and clinicians.
Read Interview
Driving the Global Development of Cancer Therapy Selection
Studies from Japan and Belgium seek to advance precision medicine in oncology
Read ArticleFeatured Products
The Changing Landscape of NGS Implementation
NGS technology has accelerated the discovery of variants associated with cancer. Some of these research discoveries became the basis for companion diagnostics and laboratory developed tests (LDT) now in use in molecular diagnostic laboratories worldwide. We spoke with key opinion leaders about the ongoing challenges and potential of NGS in oncology testing.
Read Interview
Learn More
Genomic Technologies for Cancer Research
Learn the numerous ways that genomic technologies can be applied to tumor biology.
Cancer Research Review
An overview of recent cancer genomics research publications featuring Illumina technology.
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Insights into Leukemia and Lymphoma
Munich Leukemia Laboratory is using NGS to gain a better understanding of leukemia and lymphoma subtypes and discover new therapeutic pathways.
Educational Webinars
Explore a variety of webinars on topics ranging from cancer research to NGS data analysis, microbiome studies, and more.
Sequencing Analysis of Tissue Samples: Fresh Frozen vs. FFPE
A researcher from Massachusetts General Hospital compares sequencing results from FFPE and fresh-frozen tumor samples.
References
*Data on file based on a 2013 study.